Results 31 to 40 of about 39,809 (306)

Immune response to vaccines in children with celiac disease [PDF]

open access: yes, 2017
Celiac disease (CD) is an immune-mediated systemic condition evoked by ingestion of gluten and related prolamines in genetically susceptible subjects. The disease is featured by a variable combination of clinical signs, specific antibodies, HLA-DQ2 and ...
ANANIA, Caterina   +4 more
core   +1 more source

Persistence of immune memory among adults with normal and high antibody response to primary hepatitis B vaccination: Results from a five-year follow-up study in China

open access: yesHuman Vaccines & Immunotherapeutics, 2018
Immune memory after hepatitis B vaccination among adults is still under investigation. In this study, adults who had normal and high antibody response to the primary series of hepatitis B vaccination (HepB) were followed up at 5 years after the primary ...
Wenlong Wu   +6 more
doaj   +1 more source

Prevalence of antibody to hepatitis B virus in an urban population of northeast Brazil

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 1986
A sample of 1,288 inhabitants of Salvador, Bahia, Brazil, were submitted to the determination of anti-HBs using radioimmunoassay procedure, and analysed according to age, sex and income. Overall prevalence of anti-HBs was 11,8%.
L. G. Lyra   +4 more
doaj   +1 more source

Randomized, Controlled Trial of the Long Term Safety, Immunogenicity and Efficacy of RTS,S/AS02(D) Malaria Vaccine in Infants Living in a Malaria-Endemic Region. [PDF]

open access: yes, 2013
The RTS,S/AS malaria candidate vaccine is being developed with the intent to be delivered, if approved, through the Expanded Programme on Immunization (EPI) of the World Health Organization.
A Olotu   +43 more
core   +5 more sources

Distribution of anti-HBs levels in Korean adults

open access: yesYonsei Medical Journal, 2000
Exact titration of anti-HBs with mIU/mL unit is necessary in evaluating the success of HBV vaccination or in making a decision to increase the dose of HBV vaccination. Data of distribution of anti-HBs titers can contribute to cutting of public health costs by reducing unnecessary HBV booster doses.
B M, Shin, K W, Jeong
openaire   +2 more sources

Association between Body Mass Index and Hepatitis B antibody seropositivity in children [PDF]

open access: yesKorean Journal of Pediatrics, 2019
Background The seropositivity rate of hepatitis B surface antigen (anti-HBs) antibodies is known to be ≥95% after hepatitis B virus vaccination during infancy.
Yoowon Kwon, Su Jin Jeong
doaj   +1 more source

Monitoring of post-vaccination anti-HBs titles vaccine in children and adolescents in the pre-dialysis of chronic kidney disease

open access: yesBrazilian Journal of Nephrology, 2017
Introduction: Bacterial or viral diseases are one of the major causes of death in patients with chronic kidney disease (CKD). These patients show a quantitative reduction of levels of antibodies over time.
Nathália Cristina Pereira da Costa   +3 more
doaj   +1 more source

Presence of maternal anti-HBs antibodies does not influence hepatitis B vaccine response in Brazilian neonates

open access: yesMemorias do Instituto Oswaldo Cruz, 2011
Recently, it was suggested that maternal hepatitis B surface antigen antibodies (anti-HBs) acquired transplacentally could play a negative role in newborn infants' immune response to the hepatitis B vaccine.
Ana Luiza N Junqueira   +7 more
doaj   +1 more source

The prevalence of occult hepatitis B virus (hbv) infection in a large multi-ethnic haemodialysis cohort. [PDF]

open access: yes, 2015
Haemodialysis patients are at increased risk of exposure to blood borne viruses. To reduce transmission in the UK, all haemodialysis patients are regularly screened, and if susceptible to Hepatitis B virus (HBV) infection ...
Cross, J   +6 more
core   +1 more source

Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah

open access: yesAnnals of Saudi Medicine, 2018
BACKGROUND: Globally, about 300 million people are infected with hepatitis B virus (HBV). Among the effective approaches to fight HBV infection is immunization. In 1989, an obligatory hepatitis B vaccine program was launched in Saudi Arabia.
Waleed Mahallawi
doaj   +1 more source

Home - About - Disclaimer - Privacy